Virological investigation of genetic variation of enterovirus type 71 in hand, foot and mouth disease

Wang,Yang; Li,Yi; Yang,Yuling; Peng,Chuanmei; Fu,Xiaoye; Gu,Xin; Gao,Hui

doi:10.3892/etm.2020.8728

Virological investigation of genetic variation of enterovirus type 71 in hand, foot and mouth disease

Authors:
- Yang Wang
- Yi Li
- Yuling Yang
- Chuanmei Peng
- Xiaoye Fu
- Xin Gu
- Hui Gao
View Affiliations

Affiliations: Department of Laboratory, Kunming Yanan Hospital, Kunming, Yunnan 650051, P.R. China, Department of Cell Biology and Genetics, Kunming Medical University, Chenggong, Kunming, Yunnan 650500, P.R. China
Published online on: May 7, 2020 https://doi.org/10.3892/etm.2020.8728
Pages: 543-549
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to analyze the sequence of the VP1 gene in enterovirus 71 (EV71) isolates and to explore their genetic evolution, so as to provide a scientific basis for the clinical prevention and treatment of hand, foot and mouth disease. The fecal samples of 590 patients with suspected hand, foot and mouth disease treated at Yan'an Hospital (Kunming, China) between January 2015 and December 2016 were collected and EV71 nucleic acid was detected by fluorescence PCR. The viral RNA of EV71‑positive samples was extracted, the VP1 gene was amplified by PCR and the products were sequenced. The VP1 gene sequence was analyzed using DNAMAN and MEGA (version 4.0) software and homologous modeling was performed using Pymol software. A total of 50 EV71‑positive samples were identified and the detection rate was 8.47% (50/590 cases). All of the 50 EV71 strains were of the C4 subtype. The genetic distance between the strains detected in the present study and EV71 strains detected in Beijing, Anhui and Malaysia was 0.01‑0.03, while that between the strains detected in the present study and Australian strains was 2.11. Homologous modeling indicated that the amino acid sequence of the VP1 gene of the detected strains had a H144Y mutation. There was no significant genetic variation in the EV71 strain within the 2‑year period. In conclusion, the EV71 strains detected in the present study was similar to that detected in Beijing, Anhui and Malaysia but different to that from Australia. A point mutation was present in the amino acid sequence of the VP1 gene.

View Figures

View References

1	Chen Z, Sun H, Yan Y, Wang Y, Zhu C, Zhou W, Huang L, Wang M, Mize M, Tian J and Ji W: Epidemiological profiles of hand, foot, and mouth disease, including meteorological factors, in Suzhou, China. Arch Virol. 160:315–321. 2015.PubMed/NCBI View Article : Google Scholar
2	Li L, Yin H, An Z and Feng Z: Considerations for developing an immunization strategy with enterovirus 71 vaccine. Vaccine. 33:1107–1112. 2015.PubMed/NCBI View Article : Google Scholar
3	Li H, Li S, Zheng J, Cai C, Ye B, Yang J and Chen Z: Cerebrospinal fluid Th1/Th2 cytokine profiles in children with enterovirus 71-associated meningoencephalitis. Microbiol Immunol. 59:152–159. 2015.PubMed/NCBI View Article : Google Scholar
4	Ang LW, Tay J, Phoon MC, Hsu JP, Cutter J, James L, Goh KT and Chow VT: Seroepidemiology of coxsackievirus a6, coxsackievirus a16, and enterovirus 71 infections among children and adolescents in Singapore, 2008-2010. PLoS One. 10(e0127999)2015.PubMed/NCBI View Article : Google Scholar
5	Huang X, Wei H, Wu S, Du Y, Liu L, Su J, Xu Y, Wang H, Li X, Wang Y, et al: Epidemiological and etiological characteristics of hand, foot, and mouth disease in Henan, China, 2008-2013. Sci Rep. 5(8904)2015.PubMed/NCBI View Article : Google Scholar
6	Zhou SL, Ying XL, Han X, Sun XX, Jin Q and Yang F: Characterization of the enterovirus 71 VP1 protein as a vaccine candidate. J Med Virol. 87:256–262. 2015.PubMed/NCBI View Article : Google Scholar
7	Zhang S, Wang Y and Gao H: Research progress in laboratory detection of common pathogens of hand foot and mouth disease. J Kunming Med University. 37:1–4. 2016.
8	Ministry of health of the People's Republic of China. Hand-foot-mouth disease prevention and control guidelines (2008 edition). Capital Public Health. 2:146–148. 2008.
9	Zhiqin Zhang and Guoshi Xiang: Research progress of enterovirus 71 VP1 protein. Chin J Zoonoses. 31:377–379, 390. 2015.
10	Mao Q, Wang Y, Yao X, Bian L, Wu X, Xu M and Liang Z: Coxsackievirus A16: Epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother. 10:360–367. 2014.PubMed/NCBI View Article : Google Scholar
11	Yao X, Bian LL, Mao QY, Zhu FC, Ye Q and Liang ZL: Echovirus 7 associated with hand, foot, and mouth disease in mainland China has undergone a recombination event. Arch Virol. 160:1291–1295. 2015.PubMed/NCBI View Article : Google Scholar
12	Guoquan Zhang: Observation on the curative effect of treating HFMD in adults by integrated Chinese and western medicine. Zhejiang J Integrated Chin Western Med 2014: 825-826.
13	Linghua Yu, Xinguang Yin, Xingju Wang, et al: Analysis of correlation characteristics of 41 adult hand, foot and mouth disease patients. Chin J Infectious Dis. 31:560–563. 2013.
14	Chen GP, Wu JB, Wang JJ, Pan HF, Zhang J, Shi YL, Cao C, Li FR, Fan YG, Meng FY and Ye DQ: Epidemiological characteristics and influential factors of hand, foot and mouth disease (HFMD) reinfection in children in Anhui province. Epidemiol Infect. 144:153–160. 2016.PubMed/NCBI View Article : Google Scholar
15	Zhou X, Zhu Q, Xia W, He F, Hu M, Ni X, Gao M, Chen H and Chen S: Molecular epidemiology of an outbreak of hand, foot, and mouth disease associated with subgenotype C4a of enterovirus A71 in Nanchang, China in 2014. J Med Virol. 87:2154–2158. 2015.PubMed/NCBI View Article : Google Scholar
16	Eshima N, Tokumaru O, Hara S, Bacal K, Korematsu S, Karukaya S, Uruma K, Okabe N and Matsuishi T: Age-specific sex-related differences in infections: A statistical analysis of national surveillance data in Japan. PLoS One. 7(e42261)2012.PubMed/NCBI View Article : Google Scholar
17	Jianbo Wang, Yan Li, Xiaohong Li, et al: Four cases of hand foot and mouth disease in adults and virological observation. Chin J Dermatol. 47:659–660. 2014.
18	Yubao Lian and Jinqiu Yu: A case of adult severe hand, foot and mouth disease. Chin J Clin Infect Dis. 3:376. 2010.
19	Sheng Zhang, Lingjia Li, Hui Gao, et al: Clinical report of 2 adult cases of hand foot and mouth disease and its family pathogen aggregation. Lab Med. 31:733–734. 2016.
20	Mingyu Xie, Qi Peng, Xiaomei Lu, et al: Research progress on human enterovirus 71 vaccine. Chin J Clin Pediatrics. 31:1508–1512. 2016.
21	Kataoka C, Suzuki T, Kotani O, Iwata-Yoshikawa N, Nagata N, Ami Y, Wakita T, Nishimura Y and Shimizu H: The role of VP1 amino acid residue 145 of enterovirus 71 in viral fitness and pathogenesis in a cynomolgus monkey model. PLoS Pathog. 11(e1005033)2015.PubMed/NCBI View Article : Google Scholar
22	Zongmin Fu, Xiaoling Xia, Lin Zhao, Ping Zhao and Ling Zhao: Pathogen detection and clinical characteristics analysis of hand, foot and mouth disease in kunming in 2011. J Clin Pediatrics. 31:48–51. 2013.
23	Sanders SA, Herrero LJ, McPhie K, Chow SS, Craig ME, Dwyer DE, Rawlinson W and McMinn PC: Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community. Arch Virol. 151:1003–1013. 2006.PubMed/NCBI View Article : Google Scholar
24	Wenxiang He, Yongjun Zhang, Guangmin Chen, Ying Zhu, Wei Chen and Yuwei Weng: Analysis of prevalence and genetic variation of EV71 in fujian province. Chin J Zoonoses. 33:136–142. 2017.
25	Li YX, Zhao H, Cao RY, Deng YQ, Han JF, Zhu SY, Ma J, Liu L, Qin ED and Qin CF: Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice. Virol J. 11(79)2014.PubMed/NCBI View Article : Google Scholar
26	Nishimura Y, Lee H, Hafenstein S, Kataoka C, Wakita T, Bergelson JM and Shimizu H: Enterovirus 71 Binding to PSGL-1 on Leukocytes: VP1-145 Acts as a Molecular Switch to Control Receptor Interaction. PLoS Pathog. 9(e1003511)2013.PubMed/NCBI View Article : Google Scholar